Dr Reddys declines as AbbVie Inc sues it for infringement of thyroid injection patent

19 Jun 2013 Evaluate

Dr Reddys Laboratories is currently trading at Rs. 2111.00, down by 21.10 points or 0.99% from its previous closing of Rs. 2132.10 on the BSE.

The scrip opened at Rs. 2145.90 and has touched a high and low of Rs. 2150.00 and Rs. 2094.65 respectively. So far 5262 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2207.80 on 10-Jun-2013 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 2204.40 and Rs. 2094.65 respectively. The current market cap of the company is Rs. 35919.36 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 40.69% and 16.90% respectively.

US-based drug maker AbbVie Inc, the spun-off entity of Abbott, has sued Dr Reddys Laboratories for purportedly infringing the former’s patented drug Zemplar on six counts, concerning three patents. AbbVie has demanded the court to pass an order to hold back Dr Reddys from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing Dr Reddys' generic paricalcitol injectable products prior to the expiration of said patents.

Earlier, Dr Reddys filed an ANDA (Abbreviated New Drug Application) with the US Food and Drug Administration (US FDA), seeking approval to sell a generic copy of US drug maker’s Zemplar injectable products in 2 microgram/ml and 5 microgram/ml formulations, prior to the expiration of the patents owned by and exclusively licensed to the complainants.

Dr. Reddys Lab Share Price

1187.65 1.20 (0.10%)
16-Jan-2026 13:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.45
Dr. Reddys Lab 1187.65
Cipla 1397.00
Zydus Lifesciences 878.35
Lupin 2195.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×